BillionToOne, Inc.

Equities

BLLN

US0901681058

Biotechnology & Medical Research

Market Closed - Nasdaq Other stock markets 21:00:00 16/01/2026 GMT			5-day change	1st Jan Change
88.73 ^USD	-6.32%		+3.25%	+8.42%

01-15	BillionToOne to Integrate Testing Portfolio With Epic's Diagnostics Suite	MT
01-15	BillionToOne, Inc. Announces Collaboration with Epic to Expand Prenatal and Oncology Testing Across Healthcare	CI

BillionToOne Q3 Swings to Profit, Revenue Rises; Shares Fall After Hours

Published on 12/09/2025 at 09:40 pm GMT

MT Newswires

This article is reserved for members

Unlock the article: REGISTER NOW!

100% Free Registration

Already a customer? Log In

Latest news about BillionToOne, Inc.

01-15	BillionToOne to Integrate Testing Portfolio With Epic's Diagnostics Suite	MT
01-15	BillionToOne, Inc. Announces Collaboration with Epic to Expand Prenatal and Oncology Testing Across Healthcare	CI
01-15	Billiontoone announces collaboration with Epic to expand prenatal and oncology testing across healthcare	RE
01-12	BillionToOne Reaffirms 2025 Revenue Guidance, Issues 2026 Guidance	MT
01-12	(BLLN) BillionToOne Expects 2025 Revenue Range $293M - $299M, vs. FactSet Est of $296.2M	MT
01-12	(BLLN) BillionToOne Expects 2026 Total Revenue Range $415M to $430M, vs. FactSet Est of $402.3M	MT
01-12	Billiontoone provides guidance for 2026	RE
01-12	Billiontoone, Inc. Provides Earnings Guidance for 2026	CI
01-06	BillionToOne, Inc. Announces Selection of Northstar Select as New Liquid Biopsy Test for LC-SCRUM-TRY Clinical Study at National Cancer Center Hospital East	CI
01-06	Billiontoone announces selection of Northstar Select® as the new liquid biopsy test	RE
01-06	Guggenheim Initiates BillionToOne at Buy With $120 Price Target	MT
12-21	BillionToOne, Inc.(NasdaqGS:BLLN) added to S&P TMI Index	CI
12-12	BillionToOne, Inc., Q3 2025 Earnings Call, Dec 09, 2025
12-09	BillionToOne Q3 Swings to Profit, Revenue Rises; Shares Fall After Hours	MT
12-09	(BLLN) BillionToOne Expects Full Year 2025 Revenue Range $293M - $299M, vs. FactSet Est of $288.6M	MT
12-09	Earnings Flash (BLLN) BillionToOne Posts Q3 EPS $0.10, vs. FactSet Est of $0.14	MT
12-09	(BLLN) BillionToOne, Inc. Expects Q4 Revenue Range $84.0M - $90.0M	MT
12-09	Earnings Flash (BLLN) BillionToOne, Inc. Reports Q3 Revenue $83.5M, vs. FactSet Est of $82.9M	MT
12-09	Billiontoone, Inc. Appoints Anthony Pagano to Its Board of Directors, Effective January 1, 2026	CI
12-09	BillionToOne, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025	CI
12-09	Billiontoone, Inc. Provides Earnings Guidance for Fourth Quarter and Full Year 2025	CI
12-01	BillionToOne Shares Fall After Jefferies Initiates Coverage at Hold	MT
12-01	Jefferies Initiates BillionToOne at Hold With $117 Price Target	MT
12-01	Stifel Initiates BillionToOne at Buy With $145 Price Target	MT
12-01	Piper Sandler Initiates BillionToOne at Overweight With $150 Price Target	MT